Speakers:
Prof Peter Coffey, Director of the London Project to Cure Blindness, UCL Institute of Ophthalmology
Robert McLaren, Consultant vitreoretinal surgeon and age-related macular degeneration research theme leader, Moorfields Eye Hospital
Dr Kieran Breen, Director of Research and Development, Parkinson’s UK
Prof Chris Mason, Chair of Regenerative Medicine Bioprocessing, University College London
Although stem cells are widely believed to offer tremendous hope for treatments in the future, so far no stem cell medical treatments have received market authorisation. Leading scientists are alarmed that a growing number of patients are spending large sums of money going abroad to access unregulated and unproven stem cell treatments which offer little or no benefit and at worst can be detrimental to health.